Mahmoud Balbaa

9PUBLICATIONS
2CO-AUTHORS
Molecular targetsFood properties (incl. characteristics and health benefits)Predictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 20, 2025
Thymoquinone-conjugated liposomes improve cytotoxic and proapoptotic effects against hepatocellular cancer by altering the EGFR/ERK/MEK signaling axis.

Shaymaa A Abdulmalek, Fatma A Mahmoud, Doaa Awad

|Jul 15, 2025
Biochemical and molecular evaluation of resveratrol and selenium nanoparticles in managing type 2 diabetes and its complications.

Aya Y Soliman, Nihal M Elguindy, Abdulrahman M Saleh

|Aug 10, 2022
Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.

Shaymaa Abdulmalek, Nouf Mostafa, Marwa Gomaa

|Nov 27, 2021
Protective Effect of Natural Antioxidant, Curcumin Nanoparticles, and Zinc Oxide Nanoparticles against Type 2 Diabetes-Promoted Hippocampal Neurotoxicity in Rats.

Shaymaa Abdulmalek, Mayada Nasef, Doaa Awad

|Nov 27, 2021
Therapeutic Screening of Herbal Remedies for the Management of Diabetes.

Mahmoud Balbaa, Marwa El-Zeftawy, Shaymaa A Abdulmalek

|Oct 20, 2021
Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes.

Shaymaa Abdulmalek, Asmaa Eldala, Doaa Awad

Pageof 2

Frequent Collaborators

1 joint publications

Shaymaa A Abdulmalek

1 joint publications

Marwa El-Zeftawy